North America Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Cancer), By Region And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
North America And Europe Pet Birds Health Market Growth & Trends
The North America and Europe pet birds health market size is anticipated to reach USD 849.8 million by 2030 and is projected to grow at a CAGR of 7.80% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of bacterial infections in pet birds, rising adoption of pet insurance, and increasing birds ownership are key factors driving the market growth. Moreover, the increasing availability and development of specialized pharmaceuticals and supplements for pet birds are vital. These products address common health issues, such as nutritional deficiencies, respiratory conditions, and organ function, contributing to market growth.
The increasing adoption of pet bird health insurance is contributing significantly to the market growth. As bird ownership rises, more pet owners seek to provide comprehensive care for their birds, driving demand for specialized health insurance plans. With insurance covering a range of veterinary services, owners are more inclined to seek timely and proper medical care for their birds, boosting demand for veterinary services, pharmaceuticals, and diagnostic tools. This, in turn, stimulates growth in the broader pet bird health market as more advanced and specialized care becomes accessible through insurance coverage. For instance, Nationwide offers pet insurance plans for birds. The insurance plans cover conditions that specifically affect birds, from internal parasites to liver disease. Moreover, according to Nationwide, a bird insurance plan's monthly premium typically starts at less than USD 21 per month and varies depending on the type of coverage chosen.
The rising prevalence of diseases in birds significantly drives the market by increasing the demand for specialized healthcare services and products. According to an article published by the World Organization for Animal Health, avian influenza is a highly contagious viral disease that affects both domestic and wild birds. Common avian diseases like psittacosis, avian influenza, and various parasitic and bacterial infections create a growing need for advanced diagnostic tools, vaccines, and treatments. Bird owners are becoming more aware of the importance of preventive healthcare, leading to increased veterinary visits, the adoption of health supplements, and demand for pharmaceuticals designed specifically for birds. Technological advancements in diagnostics, along with the development of more effective vaccines and treatments, are further accelerating this market. In addition, the growing focus on avian wellness by breeders and pet owners, in response to disease risks, boosts sales in both diagnostic and pharmaceutical segments. E-commerce platforms also make it easier to access a wider range of bird-specific health products, increasing their availability and driving market growth.
North America And Europe Pet Birds Health Market Report Highlights
North America And Europe Pet Birds Health Market Growth & Trends
The North America and Europe pet birds health market size is anticipated to reach USD 849.8 million by 2030 and is projected to grow at a CAGR of 7.80% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of bacterial infections in pet birds, rising adoption of pet insurance, and increasing birds ownership are key factors driving the market growth. Moreover, the increasing availability and development of specialized pharmaceuticals and supplements for pet birds are vital. These products address common health issues, such as nutritional deficiencies, respiratory conditions, and organ function, contributing to market growth.
The increasing adoption of pet bird health insurance is contributing significantly to the market growth. As bird ownership rises, more pet owners seek to provide comprehensive care for their birds, driving demand for specialized health insurance plans. With insurance covering a range of veterinary services, owners are more inclined to seek timely and proper medical care for their birds, boosting demand for veterinary services, pharmaceuticals, and diagnostic tools. This, in turn, stimulates growth in the broader pet bird health market as more advanced and specialized care becomes accessible through insurance coverage. For instance, Nationwide offers pet insurance plans for birds. The insurance plans cover conditions that specifically affect birds, from internal parasites to liver disease. Moreover, according to Nationwide, a bird insurance plan's monthly premium typically starts at less than USD 21 per month and varies depending on the type of coverage chosen.
The rising prevalence of diseases in birds significantly drives the market by increasing the demand for specialized healthcare services and products. According to an article published by the World Organization for Animal Health, avian influenza is a highly contagious viral disease that affects both domestic and wild birds. Common avian diseases like psittacosis, avian influenza, and various parasitic and bacterial infections create a growing need for advanced diagnostic tools, vaccines, and treatments. Bird owners are becoming more aware of the importance of preventive healthcare, leading to increased veterinary visits, the adoption of health supplements, and demand for pharmaceuticals designed specifically for birds. Technological advancements in diagnostics, along with the development of more effective vaccines and treatments, are further accelerating this market. In addition, the growing focus on avian wellness by breeders and pet owners, in response to disease risks, boosts sales in both diagnostic and pharmaceutical segments. E-commerce platforms also make it easier to access a wider range of bird-specific health products, increasing their availability and driving market growth.
North America And Europe Pet Birds Health Market Report Highlights
- The pharmaceuticals segment led the market with the largest revenue share of 58.33% in 2023. Bacterial and fungal infections are common among pet birds, necessitating the use of targeted pharmaceuticals. The availability of advanced antibiotics and antifungals tailored for birds has supported market growth
- Based on application, the bacterial infections segment led the market with the largest revenue share of 48.57% in 2023
- Based on distribution channel, the veterinary hospitals/clinics segment led the market with the largest revenue share of 49.48% in 2023
- Europe dominated the market with the largest revenue share of 54% in 2023 and is anticipated to grow at the fastest CAGR of 7% during the forecast period
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. NORTH AMERICA HOME HEALTHCARE MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. North America Home Healthcare Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. NORTH AMERICA HOME HEALTHCARE MARKET: COMPONENT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
4.3. Equipment
4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Therapeutic
4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.1. Home Respiratory Equipment
4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.2. Insulin Delivery Market
4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.3. Home IV Pumps
4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.4. Home Dialysis Equipment
4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.5. Other Therapeutic Equipment
4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Diagnostic
4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.1. Diabetic Care Unit
4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.2. BP Monitors
4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.3. Multi Para Diagnostic Monitors
4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.4. Home Pregnancy and Fertility Kits
4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.5. Apnea and Sleep Monitors
4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.6. Holter Monitors
4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.7. Heart Rate Meters (include pacemakers)
4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.8. Others
4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Mobility Assist
4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.1.1. Wheel Chair
4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.1.2. Home Medical Furniture
4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.1.3. Walking Assist Devices
4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Skilled Home Healthcare
4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.1. Physician Primary Care
4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.2. Nursing Care
4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.3. Physical/Occupational/Speech Therapy
4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.4. Nutritional Support
4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.5. Hospice & Palliative
4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.6. Other Skilled Nursing Services
4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Unskilled Home Healthcare
4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. NORTH AMERICA HOME HEALTHCARE MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
5.3. Cardiovascular Disorder & Hypertension
5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Diabetes & Kidney Disorders
5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Neurological & Mental Disorders
5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Respiratory Diseases & COPD
5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Maternal Disorders
5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Mobility Disorders
5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Cancer
5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Wound Care
5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Others
5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. NORTH AMERICA HOME HEALTHCARE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. B. Braun SE
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Abbott
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Sunrise Medical
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. 3M
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Baxter
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Medtronic
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Cardinal Health
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. F. Hoffmann-La Roche Ltd
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Amedisys
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. ARKRAY, Inc.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. BD
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
7.4.12. OMRON Healthcare, Inc.
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/ Strategic Initiatives
7.4.13. GE Healthcare
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/ Strategic Initiatives
7.4.14. Medline Industries, Inc
7.4.14.1. Participant’s Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/ Strategic Initiatives
7.4.15. Koninklijke Philips N.V.
7.4.15.1. Participant’s Overview
7.4.15.2. Financial Performance
7.4.15.3. Product Benchmarking
7.4.15.4. Recent Developments/ Strategic Initiatives
7.4.16. Johnson & Johnson Services, Inc.
7.4.16.1. Participant’s Overview
7.4.16.2. Financial Performance
7.4.16.3. Product Benchmarking
7.4.16.4. Recent Developments/ Strategic Initiatives
7.4.17. Acelity (3M)
7.4.17.1. Participant’s Overview
7.4.17.2. Financial Performance
7.4.17.3. Product Benchmarking
7.4.17.4. Recent Developments/ Strategic Initiatives
7.4.18. Teleflex Incorporated.
7.4.18.1. Participant’s Overview
7.4.18.2. Financial Performance
7.4.18.3. Product Benchmarking
7.4.18.4. Recent Developments/ Strategic Initiatives
7.4.19. Fresenius Kabi AG.
7.4.19.1. Participant’s Overview
7.4.19.2. Financial Performance
7.4.19.3. Product Benchmarking
7.4.19.4. Recent Developments/ Strategic Initiatives
7.4.20. Bayer AG
7.4.20.1. Participant’s Overview
7.4.20.2. Financial Performance
7.4.20.3. Product Benchmarking
7.4.20.4. Recent Developments/ Strategic Initiatives
7.4.21. GF Health Products, Inc.
7.4.21.1. Participant’s Overview
7.4.21.2. Financial Performance
7.4.21.3. Product Benchmarking
7.4.21.4. Recent Developments/ Strategic Initiatives
7.4.22. Knight Health Holdings, LLC
7.4.22.1. Participant’s Overview
7.4.22.2. Financial Performance
7.4.22.3. Product Benchmarking
7.4.22.4. Recent Developments/ Strategic Initiatives
7.4.23. NHC, National Healthcare Corporation
7.4.23.1. Participant’s Overview
7.4.23.2. Financial Performance
7.4.23.3. Product Benchmarking
7.4.23.4. Recent Developments/ Strategic Initiatives
7.4.24. Gentiva
7.4.24.1. Participant’s Overview
7.4.24.2. Financial Performance
7.4.24.3. Product Benchmarking
7.4.24.4. Recent Developments/ Strategic Initiatives
7.4.25. Medco Home Healthcare, Inc.
7.4.25.1. Participant’s Overview
7.4.25.2. Financial Performance
7.4.25.3. Product Benchmarking
7.4.25.4. Recent Developments/ Strategic Initiatives
7.4.26. Brookdale Senior Living Inc.
7.4.26.1. Participant’s Overview
7.4.26.2. Financial Performance
7.4.26.3. Product Benchmarking
7.4.26.4. Recent Developments/ Strategic Initiatives
7.4.27. Sunrise Senior Living
7.4.27.1. Participant’s Overview
7.4.27.2. Financial Performance
7.4.27.3. Product Benchmarking
7.4.27.4. Recent Developments/ Strategic Initiatives
7.4.28. Genesis HealthCare
7.4.28.1. Participant’s Overview
7.4.28.2. Financial Performance
7.4.28.3. Product Benchmarking
7.4.28.4. Recent Developments/ Strategic Initiatives
7.4.29. EXTENDICARE.
7.4.29.1. Participant’s Overview
7.4.29.2. Financial Performance
7.4.29.3. Product Benchmarking
7.4.29.4. Recent Developments/ Strategic Initiatives
7.4.30. Diversicare.
7.4.30.1. Participant’s Overview
7.4.30.2. Financial Performance
7.4.30.3. Product Benchmarking
7.4.30.4. Recent Developments/ Strategic Initiatives
7.4.31. Home Instead, Inc.
7.4.31.1. Participant’s Overview
7.4.31.2. Financial Performance
7.4.31.3. Product Benchmarking
7.4.31.4. Recent Developments/ Strategic Initiatives
7.4.32. Senior Services of America
7.4.32.1. Participant’s Overview
7.4.32.2. Financial Performance
7.4.32.3. Product Benchmarking
7.4.32.4. Recent Developments/ Strategic Initiatives
7.4.33. Atria Senior Living, Inc
7.4.33.1. Participant’s Overview
7.4.33.2. Financial Performance
7.4.33.3. Product Benchmarking
7.4.33.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. NORTH AMERICA HOME HEALTHCARE MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. North America Home Healthcare Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. NORTH AMERICA HOME HEALTHCARE MARKET: COMPONENT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
4.3. Equipment
4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Therapeutic
4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.1. Home Respiratory Equipment
4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.2. Insulin Delivery Market
4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.3. Home IV Pumps
4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.4. Home Dialysis Equipment
4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.1.5. Other Therapeutic Equipment
4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Diagnostic
4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.1. Diabetic Care Unit
4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.2. BP Monitors
4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.3. Multi Para Diagnostic Monitors
4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.4. Home Pregnancy and Fertility Kits
4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.5. Apnea and Sleep Monitors
4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.6. Holter Monitors
4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.7. Heart Rate Meters (include pacemakers)
4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.1.8. Others
4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Mobility Assist
4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.1.1. Wheel Chair
4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.1.2. Home Medical Furniture
4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.1.3. Walking Assist Devices
4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Skilled Home Healthcare
4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.1. Physician Primary Care
4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.2. Nursing Care
4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.3. Physical/Occupational/Speech Therapy
4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.4. Nutritional Support
4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.5. Hospice & Palliative
4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.1.6. Other Skilled Nursing Services
4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Unskilled Home Healthcare
4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. NORTH AMERICA HOME HEALTHCARE MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
5.3. Cardiovascular Disorder & Hypertension
5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Diabetes & Kidney Disorders
5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Neurological & Mental Disorders
5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Respiratory Diseases & COPD
5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Maternal Disorders
5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Mobility Disorders
5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Cancer
5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Wound Care
5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Others
5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. NORTH AMERICA HOME HEALTHCARE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. B. Braun SE
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Abbott
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Sunrise Medical
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. 3M
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Baxter
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Medtronic
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Cardinal Health
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. F. Hoffmann-La Roche Ltd
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Amedisys
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. ARKRAY, Inc.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. BD
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
7.4.12. OMRON Healthcare, Inc.
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/ Strategic Initiatives
7.4.13. GE Healthcare
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/ Strategic Initiatives
7.4.14. Medline Industries, Inc
7.4.14.1. Participant’s Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/ Strategic Initiatives
7.4.15. Koninklijke Philips N.V.
7.4.15.1. Participant’s Overview
7.4.15.2. Financial Performance
7.4.15.3. Product Benchmarking
7.4.15.4. Recent Developments/ Strategic Initiatives
7.4.16. Johnson & Johnson Services, Inc.
7.4.16.1. Participant’s Overview
7.4.16.2. Financial Performance
7.4.16.3. Product Benchmarking
7.4.16.4. Recent Developments/ Strategic Initiatives
7.4.17. Acelity (3M)
7.4.17.1. Participant’s Overview
7.4.17.2. Financial Performance
7.4.17.3. Product Benchmarking
7.4.17.4. Recent Developments/ Strategic Initiatives
7.4.18. Teleflex Incorporated.
7.4.18.1. Participant’s Overview
7.4.18.2. Financial Performance
7.4.18.3. Product Benchmarking
7.4.18.4. Recent Developments/ Strategic Initiatives
7.4.19. Fresenius Kabi AG.
7.4.19.1. Participant’s Overview
7.4.19.2. Financial Performance
7.4.19.3. Product Benchmarking
7.4.19.4. Recent Developments/ Strategic Initiatives
7.4.20. Bayer AG
7.4.20.1. Participant’s Overview
7.4.20.2. Financial Performance
7.4.20.3. Product Benchmarking
7.4.20.4. Recent Developments/ Strategic Initiatives
7.4.21. GF Health Products, Inc.
7.4.21.1. Participant’s Overview
7.4.21.2. Financial Performance
7.4.21.3. Product Benchmarking
7.4.21.4. Recent Developments/ Strategic Initiatives
7.4.22. Knight Health Holdings, LLC
7.4.22.1. Participant’s Overview
7.4.22.2. Financial Performance
7.4.22.3. Product Benchmarking
7.4.22.4. Recent Developments/ Strategic Initiatives
7.4.23. NHC, National Healthcare Corporation
7.4.23.1. Participant’s Overview
7.4.23.2. Financial Performance
7.4.23.3. Product Benchmarking
7.4.23.4. Recent Developments/ Strategic Initiatives
7.4.24. Gentiva
7.4.24.1. Participant’s Overview
7.4.24.2. Financial Performance
7.4.24.3. Product Benchmarking
7.4.24.4. Recent Developments/ Strategic Initiatives
7.4.25. Medco Home Healthcare, Inc.
7.4.25.1. Participant’s Overview
7.4.25.2. Financial Performance
7.4.25.3. Product Benchmarking
7.4.25.4. Recent Developments/ Strategic Initiatives
7.4.26. Brookdale Senior Living Inc.
7.4.26.1. Participant’s Overview
7.4.26.2. Financial Performance
7.4.26.3. Product Benchmarking
7.4.26.4. Recent Developments/ Strategic Initiatives
7.4.27. Sunrise Senior Living
7.4.27.1. Participant’s Overview
7.4.27.2. Financial Performance
7.4.27.3. Product Benchmarking
7.4.27.4. Recent Developments/ Strategic Initiatives
7.4.28. Genesis HealthCare
7.4.28.1. Participant’s Overview
7.4.28.2. Financial Performance
7.4.28.3. Product Benchmarking
7.4.28.4. Recent Developments/ Strategic Initiatives
7.4.29. EXTENDICARE.
7.4.29.1. Participant’s Overview
7.4.29.2. Financial Performance
7.4.29.3. Product Benchmarking
7.4.29.4. Recent Developments/ Strategic Initiatives
7.4.30. Diversicare.
7.4.30.1. Participant’s Overview
7.4.30.2. Financial Performance
7.4.30.3. Product Benchmarking
7.4.30.4. Recent Developments/ Strategic Initiatives
7.4.31. Home Instead, Inc.
7.4.31.1. Participant’s Overview
7.4.31.2. Financial Performance
7.4.31.3. Product Benchmarking
7.4.31.4. Recent Developments/ Strategic Initiatives
7.4.32. Senior Services of America
7.4.32.1. Participant’s Overview
7.4.32.2. Financial Performance
7.4.32.3. Product Benchmarking
7.4.32.4. Recent Developments/ Strategic Initiatives
7.4.33. Atria Senior Living, Inc
7.4.33.1. Participant’s Overview
7.4.33.2. Financial Performance
7.4.33.3. Product Benchmarking
7.4.33.4. Recent Developments/ Strategic Initiatives
